Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$153K Buy
118,037
+37,956
+47% +$52.3K ﹤0.01% 3371
2026
Q1
$103K Sell
80,081
-31,166
-28% -$51.5K ﹤0.01% 3091
2025
Q4
$246K Sell
111,247
-61,933
-36% -$116K 0.01% 2245
2025
Q3
$281K Buy
173,180
+115,538
+200% +$242K 0.01% 1553
2025
Q2
$149K Buy
+57,642
New +$227K 0.01% 1791
2025
Q1
Sell
-21,555
Closed -$146K 2788
2024
Q4
$146K Buy
+21,555
New +$142K 0.01% 1673
2024
Q3
Sell
-34,968
Closed -$222K 2375
2024
Q2
$222K Buy
+34,968
New +$269K 0.02% 1169
2024
Q1
Sell
-23,641
Closed -$301K 2123
2023
Q4
$301K Buy
+23,641
New +$246K 0.07% 612
2021
Q3
Sell
-6,208
Closed -$274K 893
2021
Q2
$274K Buy
+6,208
New +$270K 0.09% 414

Other funds holding LUNG

XTX Topco's LUNG Position: Q2 2026 in Review

XTX Topco increased its Pulmonx (LUNG) stake by 47% in Q2 2026, buying an estimated $52.3K and bringing the position to 118,037 shares worth $153K. The position accounts for ﹤0.01% of the portfolio, ranked #3371.

XTX Topco first reported a position in LUNG in Q2 2021 and has held it in 9 quarters since. The position peaked at $301K in Q4 2023. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • XTX Topco held 118,037 shares of Pulmonx worth $153K as of Q2 2026.
  • XTX Topco bought 37,956 Pulmonx shares in Q2 2026, an estimated $52.3K.
  • Pulmonx made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3371 holding.
  • XTX Topco first reported a position in Pulmonx in Q2 2021 and has held it in 9 quarters since.
  • XTX Topco's Pulmonx position peaked at $301K in Q4 2023.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.